Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Prostate Cancer

  Free Subscription


01.07.2019

2 BMC Cancer
1 Cancer
3 Eur Urol
2 Int J Cancer
2 Int J Urol
6 J Urol
1 PLoS One
1 Proc Natl Acad Sci U S A
3 Prostate
1 Radiology
1 Urol Int
3 Urology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Cancer

  1. KIENER M, Chen L, Krebs M, Grosjean J, et al
    miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo.
    BMC Cancer. 2019;19:627.
    PubMed     Text format     Abstract available

  2. BECKMANN K, Russell B, Josephs D, Garmo H, et al
    Chronic inflammatory diseases, anti-inflammatory medications and risk of prostate cancer: a population-based case-control study.
    BMC Cancer. 2019;19:612.
    PubMed     Text format     Abstract available


    Cancer

  3. ERIM DO, Bensen JT, Mohler JL, Fontham ETH, et al
    Prevalence and predictors of probable depression in prostate cancer survivors.
    Cancer. 2019 Jun 27. doi: 10.1002/cncr.32338.
    PubMed     Text format     Abstract available


    Eur Urol

  4. KOTE-JARAI Z, Leongamornlert DA, Saunders EJ, Conti DV, et al
    Reply to Xiaoling Lin, Brian T. Helfand, and Jianfeng Xu's Letter to the Editor re: Daniel A. Leongamornlert, Edward J. Saunders, Sarah Wakerell, et al. Germline DNA Repair Gene Mutations in Young-onset Prostate Cancer Cases in the UK: Evidence for a
    Eur Urol. 2019 Jun 21. pii: S0302-2838(19)30491.
    PubMed     Text format    

  5. QIAN K, Ju L, Xiao Y
    Re: Stacy Loeb, Jacob Taylor, Mohit Butaney, et al. Twitter-based Prostate Cancer Journal Club (#ProstateJC) Promotes Multidisciplinary Global Scientific Discussion and Research Dissemination. Eur Urol 2019;75:881-2.
    Eur Urol. 2019 Jun 19. pii: S0302-2838(19)30454.
    PubMed     Text format    

  6. LAM HM, Nguyen HM, Labrecque MP, Brown LG, et al
    Durable Response of Enzalutamide-resistant Prostate Cancer to Supraphysiological Testosterone Is Associated with a Multifaceted Growth Suppression and Impaired DNA Damage Response Transcriptomic Program in Patient-derived Xenografts.
    Eur Urol. 2019 Jun 18. pii: S0302-2838(19)30449.
    PubMed     Text format     Abstract available


    Int J Cancer

  7. LI H, Kim C, Liu W, Zhu J, et al
    Olfactomedin 4 downregulation is associated with tumor initiation, growth, and progression in human prostate cancer.
    Int J Cancer. 2019 Jun 26. doi: 10.1002/ijc.32535.
    PubMed     Text format     Abstract available

  8. KOGEVINAS M, Espinosa A, Papantoniou K, Aragones N, et al
    Prostate cancer risk decreases following cessation of night shift work.
    Int J Cancer. 2019 Jun 24. doi: 10.1002/ijc.32528.
    PubMed     Text format     Abstract available


    Int J Urol

  9. KOGUCHI T, Haga N, Matsuoka K, Yabe M, et al
    Atherosclerosis as a predictor of transient exacerbation of overactive bladder symptoms after robot-assisted laparoscopic radical prostatectomy.
    Int J Urol. 2019;26:234-240.
    PubMed     Text format     Abstract available

  10. TAKEDA T, Benfante NE, Assel M, Mulhall JP, et al
    Erectile function recovery at 12 months after radical prostatectomy for prostate cancer is not associated with overall survival.
    Int J Urol. 2019 Jun 25. doi: 10.1111/iju.14043.
    PubMed     Text format    


    J Urol

  11. TANEJA SS
    Re: Use of Active Surveillance or Watchful Waiting for Low-Risk Prostate Cancer and Management Trends across Risk Groups in the United States, 2010-2015.
    J Urol. 2019 Jun 24:10109701JU00005749769074752.
    PubMed     Text format    

  12. RESNICK MJ
    Re: Use of Active Surveillance or Watchful Waiting for Low-Risk Prostate Cancer and Management Trends across Risk Groups in the United States, 2010-2015.
    J Urol. 2019 Jun 24:10109701JU000057441601701.
    PubMed     Text format    

  13. TANEJA SS
    Re: Prostate Cancer Genomic Classifier Relates More Strongly to Gleason Grade Group than Prostate Imaging Reporting and Data System Score in Multiparametric Prostate Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsies.
    J Urol. 2019 Jun 24:10109701JU000056971634429.
    PubMed     Text format    

  14. FAROLFI A, Gafita A, Calais J, Eiber M, et al
    (68)Ga-PSMA-11 PET Detects Residual Prostate Cancer after Prostatectomy in a Multicenter Retrospective Study.
    J Urol. 2019 Jun 24:101097JU0000000000000417. doi: 10.1097/JU.0000000000000417.
    PubMed     Text format     Abstract available

  15. HANSON HA, Martin C, O'Neil B, Leiser CL, et al
    The Relative Importance of Race Compared to Healthcare and Social Factors in Predicting Prostate Cancer Mortality: A Random Forest Approach.
    J Urol. 2019 Jun 27:101097JU0000000000000416. doi: 10.1097/JU.0000000000000416.
    PubMed     Text format     Abstract available

  16. MANNAERTS CK, Wildeboer RR, Remmers S, van Kollenburg RAA, et al
    Multiparametric ultrasound for prostate cancer detection and localization: Correlation of B-mode, shearwave elastography and contrast-enhanced ultrasound with radical prostatectomy specimens.
    J Urol. 2019 Jun 27:101097JU0000000000000415. doi: 10.1097/JU.0000000000000415.
    PubMed     Text format     Abstract available


    PLoS One

  17. JARRARD WE, Schultz A, Etheridge T, Damodaran S, et al
    Screening of urine identifies PLA2G16 as a field defect methylation biomarker for prostate cancer detection.
    PLoS One. 2019;14:e0218950.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A


  18. Correction for Geng et al., Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover.
    Proc Natl Acad Sci U S A. 2019 Jun 24. pii: 1908767116.
    PubMed     Text format    


    Prostate

  19. PILLING AB, Hwang C
    Targeting prosurvival BCL2 signaling through Akt blockade sensitizes castration-resistant prostate cancer cells to enzalutamide.
    Prostate. 2019;79:1347-1359.
    PubMed     Text format     Abstract available

  20. KNUUTTILA E, Riikonen J, Syvala H, Auriola S, et al
    Access and concentrations of atorvastatin in the prostate in men with prostate cancer.
    Prostate. 2019 Jun 24. doi: 10.1002/pros.23863.
    PubMed     Text format     Abstract available

  21. JOENTAUSTA RM, Murtola TJ
    Prostate cancer survival among statin users after prostatectomy in a Finnish nationwide cohort. Prostate. 2019;79:583-591.
    Prostate. 2019 Jun 24. doi: 10.1002/pros.23870.
    PubMed     Text format    


    Radiology

  22. PEREZ-LOPEZ R, Tunariu N, Padhani AR, Oyen WJG, et al
    Imaging Diagnosis and Follow-up of Advanced Prostate Cancer: Clinical Perspectives and State of the Art.
    Radiology. 2019 Jun 25:181931. doi: 10.1148/radiol.2019181931.
    PubMed     Text format     Abstract available


    Urol Int

  23. DEMIRTAS A, Sonmez G, Tombul ST, Demirtas T, et al
    Comparison of the Upgrading Rates of International Society of Urological Pathology Grades and Tumor Laterality in Patients Undergoing Standard 12-Core Prostate Biopsy versus Fusion Prostate Biopsy for Prostate Cancer.
    Urol Int. 2019 Jun 26:1-6. doi: 10.1159/000501528.
    PubMed     Text format     Abstract available


    Urology

  24. PICKERSGILL NA, Vetter JM, Raval NS, Andriole GL, et al
    The Accuracy of Prostate Magnetic Resonance Imaging Interpretation: Impact of the Individual Radiologist and Clinical Factors.
    Urology. 2019;127:68-73.
    PubMed     Text format     Abstract available

  25. BEKSAC AT, Sobotka S, Xu P, Gupta A, et al
    Downgrading of Grade Group After Radical Prostatectomy: Comparison of Multiparametric Magnetic Resonance Imaging Guided Fusion Biopsy and Standard 12-Core Biopsy.
    Urology. 2019;127:80-85.
    PubMed     Text format     Abstract available

  26. LOH-DOYLE JC, Ashrafi A, Nazemi A, Ghodoussipour S, et al
    Dual Prosthetic Implantation After Radical Cystoprostatectomy and Neobladder: Outcomes of the Inflatable Penile Prosthesis and Artificial Urinary Sphincter in Bladder Cancer Survivors.
    Urology. 2019 Jan 18. pii: S0090-4295(19)30065.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: